Dr. Cremieux has a broad range of expertise in health economics, antitrust, statistics (biostatistics and econometrics), and labor economics. He has consulted to numerous clients in the United States and Canada, and has testified in bench and jury trials, arbitrations, and administrative proceedings. Dr. Cremieux has served as an expert and supported other experts in both litigation and non-litigation matters on antitrust, intellectual property, and general commercial damages issues, as both an economist and statistician. His case work spans a wide array of industries, including high technology, pharmaceuticals, music and entertainment, and manufacturing products. He has testified in cases involving class certification, liability, and damages. Dr. Cremieux has published extensively on topics such as the value of pharmaceuticals, hospital performance, quality and cost of care, the economics of obesity, and a variety of labor-related issues. He has also published on litigation-related topics, including class certification, product liability, global antitrust enforcement, and the use of econometric methods. Dr. Cremieux is a signatory to multiple amicus briefs and has published more than 70 articles in academic journals and various American Bar Association publications in numerous peer-reviewed journals including the American Bar Association Economics Committee Newsletter, the Review of Economics and Statistics, and the American Journal of Managed Care. His research has been cited in leading media outlets, including The Wall Street Journal and Forbes. Dr. Cremieux is an adjunct professor at the University of Quebec at Montreal and lectures on global antitrust at the Yale School of Management.